IP Library Granted Patent US 8,834,844
Granted Patent B2
US 8,834,844 · App. 13/566,785 · Granted Sep 16, 2014

Chemical exchange saturation transfer based MRI using reporter genes and MRI methods related thereto

Inventors: Peter C. M. van Zijl (Ellicott City, MD); Assaf A. Gilad (Bethesda, MD); Jeff Bulte (Fulton, MD); Michael T. Mcmahon (Baltimore, MD); Raman Venu (Ellicott City, MD); Paul T. Winnard, Jr. (Glen Burnie, MD)
Assignee: The Johns Hopkins University
A61K49/14A61B5/055A61B6/481
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,834,844
App. No.
13/566,785
Granted
Sep 16, 2014
Kind
B2
Abstract

Featured are a new class of reporter genes including reporter compositions as well as methods, MRI systems and MRI imaging kits related thereto. The genes according to the present invention provide MR contrast when the sample/subject is irradiated at a specific off-resonance radio-frequency (RF frequency), where the contrast mechanism utilizes chemical exchange saturation transfer (CEST) technique for imaging.

Claims (9)

1. A magnetic resonance imaging system comprising:

an imaging apparatus configured to image one or more cells comprising a non-metallic reporter gene using a CEST magnetic resonance imaging (MRI) technique without binding of metallic or exogenous substrates or agents; wherein

the non-metallic reporter gene encodes a protein that is enriched with an amino acid from the list consisting of lysine, argentine, histidine, cysteine, tyrosine and serine and is used as a contrast agent.

2. The magnetic resonance imaging system of claim 1 , further comprising a second non-metallic paramagnetic reporter gene, wherein the second non-paramagnetic reporter gene is different from the first non-paramagnetic reporter gene and encodes a lysine rich protein, an arginine rich protein, a histidine rich protein, cysteine rich protein, a tyrosine rich protein or a serine rich protein.

3. The magnetic resonance imaging system of claim 1 , wherein the non-paramagnetic reporter gene encodes a lysine rich protein (LRP) and the contrast agent further comprises a therapeutically effective carrier.

4. The magnetic resonance imaging system of claim 3 , wherein the LRP comprises from between about 50 to about 250 lysines.

5. The magnetic resonance imaging system of claim 3 , wherein the LRP protein encoded by the reporter gene is functional under normal physiological conditions.

6. The magnetic resonance imaging system of claim 5 , wherein normal physiological conditions comprise a pH from between about 6.8 to about 7.5.

7. The magnetic resonance imaging system of claim 3 , wherein the LRP protein encoded by the reporter gene is not functional under ischemic or apoptotic conditions.

Assignments (1)
CONFIRMATORY LICENSE Recorded Oct 30, 2017
From: JOHNS HOPKINS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 043982/0080 →
Continuity (3)
Division 11883533
Provisional Application 60650746 · Feb 7, 2005
Related Publication 20130058874A1 · Mar 7, 2013